StonvexLoading…
StonvexStonvexStonvexCore line items from UDR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.36M | $8.32M | $6.84M | $5.02M |
Operating Income | $553.61M | $284.57M | $635.01M | $250.81M |
Net Income | $377.70M | $89.58M | $444.35M | $86.92M |
EPS (Diluted) | $1.13 | $0.26 | $1.34 | $0.26 |
Total Assets | $10.61B | $10.90B | $11.37B | $11.04B |
Total Liabilities | $6.46B | $6.44B | $6.42B | $6.10B |
Cash & Equivalents | $1.22M | $1.33M | $2.92M | $1.19M |
Free Cash Flow OCF − CapEx | $650.03M | $626.96M | $537.22M | $605.24M |
Shares Outstanding | 328.27M | 330.86M | 329.01M | 328.99M |